Abstract
Abstract
Background
Acute kidney injury (AKI) with sepsis increases mortality significantly. The pathophysiology of AKI during sepsis is complex and multifactorial. Lower heart rate is associated with better survival in patients with multiple organ dysfunction syndrome (MODS), a disease mostly caused by sepsis. In our study, we hypnotized that use of ivardrabine as heart rate reducing agent in septic patient with renal impairment may improve renal function.
Results
Fifty patients with sepsis with early renal impairment were divided in 1: 1 ratio to receive Ivabradine (group I) or not (group C). The average age of the included patients was almost 45 years, chest disorders were the main cause of sepsis in both groups. There were statistically significant differences between both groups in terms of reduction of heart rate group (I) (68.13 ± 3.34) versus (group C) (87.04 ± 3.23) and (P < 0.001) also, improvement in eGFR by Cystatin c in group (I) (103.32 ± 6.96) versus (group C) (96.25 ± 6.36) and (P < 0.001) also vasopressor dosage consumption (P < 0.001). As regards secondary outcomes, there were no statistically significant differences between study’s groups in terms of length of hospital stay (P = 0.390), need for hemodialysis (P = 0.384), and mortality (P = 1.000).
Conclusions
We concluded that Ivabradine as an adjuvant therapy in septic patients with renal impairment is promising agent to reduce such impairment.
Trial registration
Pan African Clinical Trial Registry: Identification number for the registry is PACTR201911806644230.
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Bagshaw SM, George C, Bellomo R (2007) ANZICS database management committe: changes in the incidence and outcomes for early acute kidney injury in A cohort of Austrialian intensive care units. Crit Care 11:R68
2. Bedet A, Voiriot G, Ternacle J, Marcos E, Adnot S, Derumeaux G et al (2020) Heart rate control during experimental sepsis in mice comparison of ivabradine and β-Blockers. Anesthesiology 132:321–329
3. Bellomo R, Ronco C, Kellum JA et al (2004) Palevsky P and the ADQI workgroup. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8
4. de Castilho FM, Ribeiro ALP, da Silva JLP, Nobre V, de Sousa MR (2017) Heart rate variability as predictor of mortality in sepsis: a prospective cohort study. PLoS One 12(6):e0180060. Epub 2017/06/28. https://doi.org/10.1371/journal.pone.0180060
5. De Santis V, Frati G, Greco E, Tritapepe L (2014) Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome. Clin Res Cardiol 103(10):831–834